| Bid Price | 9.50p | High Price | 10.48p |
|---|
| Ask Price | 10.50p | Low Price | 9.50p |
|---|
| Open Price | 10.00p | Spread | 9.52% |
|---|
| Prev Close | 10.00p | Volume | 17,727 |
|---|
Optibiotix Health PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Sep 16, 2025 | 11.00 | 11.50 | 9.46 | 10.00 | 911,172 |
| Sep 15, 2025 | 10.25 | 10.50 | 10.00 | 10.25 | 72,953 |
| Sep 12, 2025 | 10.25 | 10.50 | 10.00 | 10.25 | 151,170 |
| Sep 11, 2025 | 10.25 | 10.50 | 10.11 | 10.25 | 39,570 |
| Sep 10, 2025 | 10.25 | 10.50 | 10.11 | 10.25 | 24,347 |
Optibiotix Health PLC Information
| Name | Optibiotix Health PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BP0RTP38 | Epic | OPTI |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 20,000 | Trading Status | Regular Trading |
|---|
| Shares in Issue | 103.30 m | Prev Close | 10.00p |
|---|
| PE Ratio | 9.496676 | Market Cap | £9.94 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.01 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.139969 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 4.61087 | Quick Ratio | 3.708696 |
|---|
Optibiotix Health PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 28/03/24 | PLAC | Graham Myers | RES | 125,000 @ £0.20 | £25,000.00 |
| 31/08/21 | BUY | Stephen Hammond | RES | 25,000 @ £0.54 | £13,500.00 |
| 21/04/21 | BUY | Stephen O'Hara | CEO | 47,857 @ £0.53 | £25,364.00 |
| 16/04/21 | BUY | Stephen Hammond | RES | 25,000 @ £0.52 | £12,950.00 |
| 17/04/20 | BUY | Richard Davidson | CH | 25,000 @ £0.40 | £10,000.00 |
| 17/04/20 | PLAC | Stephen O'Hara | CEO | 62,500 @ £0.40 | £25,000.00 |
| 17/04/20 | PLAC | Michael Christie | NED | 25,000 @ £0.40 | £10,000.00 |
| 17/04/20 | PLAC | Frederic Narbel | RES | 16,250 @ £0.40 | £6,500.00 |
| 16/03/20 | BUY | Frederic Narbel | RES | 22,500 @ £0.40 | £8,888.00 |
| 16/03/20 | BUY | Frederic Narbel | RES | 3,200 @ £0.38 | £1,229.00 |
Optibiotix Health PLC News
